SEC Form 4 · accession 0001093557-16-000549
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barbara Kahn
Director
Period of report
May 25, 2016
Accepted (ET)
May 26, 2016 · 8:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 25, 2016 | A | 4,791 | $0.001 | A | 47,595 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Share units are restricted and subject to vesting in one annual installment from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. common stock.
- F2Included in this number are 9,070 unvested restricted stock units, 4,791 of which were granted on May 25, 2016 and shall vest on May 25, 2017 and 4,279 of which were granted on June 3, 2015 and shall vest on June 3, 2016.